Industry Insights

  1. Successfully Navigating Opportunities With On-Body Delivery Systems 4/23/2026

    Drawing on insights from the global regulatory landscape, industry trends, and direct feedback from customers, Dr. Di Wu addresses some of the most frequently asked questions about on-body delivery system requirements.

  2. Implementing Medium And High-Volume Drug Handling And Packaging Programs 4/23/2026

    Simplify the complexity of combination product development by partnering for integrated support across device design, industrialization, manufacturing, and final product assembly.

  3. Package With A Purpose 4/21/2026

    Packaging shapes how devices are understood, handled, and used. A human-centered approach surfaces critical info sooner, reduces errors, and strengthens safety and usability.

  4. Safeguarding Biologic Integrity Through Enhanced Component Compatibility 4/21/2026

    For sensitive biologics and viral vectors, risk extends beyond simple contamination. Utilizing inert barrier films on contact surfaces reduces compound migration and adsorption, maintaining dosage accuracy.

  5. Optimizing Syringe Performance For Reliable Drug Delivery 4/21/2026

    Reliable drug delivery requires precision. Maintaining a robust seal throughout a product’s shelf life is essential to preserve sterility and ensure patient safety during self-administration.

  6. Maintaining Sterility Through Precise Component Design And Manufacture 4/21/2026

    Prioritizing high-quality component design and manufacturing excellence can mitigate risks, ensure long-term container closure integrity, and avoid the costly delays associated with non-compliance.

  7. How Regulatory Is Becoming An Increasingly Valuable Asset 4/20/2026

    Build regulatory strategy into your company from day one — not as support, but as a core driver of value, risk management, and successful commercialization.

  8. A New Standard For Production Efficiency And GxP Compliance 4/20/2026

    Traditional MES platforms were built for stable environments that no longer exist. Manufacturers are now adopting composable execution architectures to reduce friction and adapt faster.

  9. Why Composable Manufacturing Execution Is Becoming The New Standard 4/20/2026

    Low-code MES promises speed, but agility comes from ownership. Composable, no-code approaches give operations teams the ability to change workflows themselves and respond faster to disruption.

  10. Unlocking The Promise Of NAMs 4/17/2026

    Human-relevant models are reshaping safety and efficacy decisions, but impact depends on selecting the right tools, integrating evidence, and turning complex data into clear, decision‑ready insights.